Atrium Therapeutics kent aandelenopties toe aan nieuwe medewerkers

Atrium Therapeutics has announced inducement grants under Nasdaq Listing Rule 5635(c)(4), a provision that allows companies to issue equity awards to new employees outside of existing shareholder-approved plans. Such grants are typically used to attract new hires by offering stock-based compensation. No further details about the size or recipients of the grants were provided in the announcement.